BioMark Revenue and Competitors
Estimated Revenue & Valuation
- BioMark's estimated annual revenue is currently $5.2M per year.
- BioMark's estimated revenue per employee is $112,000
Employee Data
- BioMark has 46 Employees.
- BioMark grew their employee count by 5% last year.
BioMark's People
| Name | Title | Email/Phone |
|---|
BioMark Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 90 | -36% | $14.1M | N/A |
#2 | $83.2M | 468 | -3% | $251M | N/A |
#3 | $14M | 100 | 1% | N/A | N/A |
#4 | $14.6M | 0 | N/A | $12.5M | N/A |
#5 | $30.3M | 197 | -6% | N/A | N/A |
#6 | $0.1M | 6 | -25% | $2.6M | N/A |
#7 | $45.1M | 293 | 2% | N/A | N/A |
#8 | $4.8M | 43 | -7% | N/A | N/A |
#9 | $399.3M | 2037 | 40% | N/A | N/A |
#10 | $44M | 286 | 4% | N/A | N/A |
What Is BioMark?
BioMark is on a mission to get the world biomarking - a global preventative healthcare movement based on empowering people with the knowledge to live their best lives. Founded on the belief that prevention is better than cure, BioMark was established in 2017 by a team of medical professionals and healthcare entrepreneurs passionate about transforming the way healthcare is delivered. BioMark won the Best Health-tech Startup in the ASEAN region in 2018 for the Asean Rice Bowl Startups Awards.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$5.2M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioMark News
... works performed with Quebec-based Phytronix Technologies Inc. BioMark Diagnostics Inc shares C.BUX are trading unchanged at $0.22.
BioMark is developing proprietary, non-invasive, and accurate liquid biopsy-based cancer diagnostic solutions which can help detect, monitor,...
GS Biomark serves hospitals, labs, large employer groups, schools, and events, she notes, remarking that it strives to make respiratory...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 46 | -2% | N/A |
#2 | $9.9M | 46 | -16% | N/A |
#3 | $6.1M | 46 | 31% | N/A |
#4 | $5.3M | 46 | 48% | N/A |
#5 | $12.1M | 46 | 0% | N/A |